Nair, Radhika
Haynes, Virginia S.
Siadaty, Mir
Patel, Nick C.
Fleisher, Adam S.
Van Amerongen, Derek
Witte, Michael M.
Downing, AnnCatherine M.
Fernandez, Leslie Ann Hazel
Saundankar, Vishal
Ball, Daniel E.
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 19 October 2017
Accepted: 16 September 2018
First Online: 16 October 2018
Ethics approval and consent to participate
: This study was reviewed and received approval from Schulman IRB.
: Not applicable.
: <tt>○</tt> Virginia S. Haynes, Adam S. Fleisher, Michael Witte, AnnCatherine Downing, are full-time employees and stockholders of Eli Lilly and Company.<tt>○</tt> Daniel E. Ball is a stockholder of Eli Lilly and Company.<tt>○</tt> Radhika Nair and Nick Patel are employees of Comprehensive Health Insights, Humana Inc., which received funding and Sponsorship from Eli Lilly and Humana to conduct this study.<tt>○</tt> Vishal Saundankar, Mir Siadaty, and Leslie Hazel-Fernandez, were employees of Comprehensive Health Insights, Humana Inc. at the time of the study.<tt>○</tt> Daniel E. Ball was an employee of Eli Lilly and Company at the time of the study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.